Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Tadd Lazarus, Howard Jacob, Dawn Berry, and More

Tadd Lazarus

Clinical Genomics has appointed Tadd Lazarus as chief medical officer. Lazarus most recently served as senior vice president and chief medical officer for Luminex. He also served as chief medical officer and head of medical and scientific affairs, reimbursement, and public policy at Qiagen from 2013 to 2016. Lazarus also was previously employed by Gen-Probe (now Hologic) as chief medical officer and VP of clinical affairs. He began his career at Roche Diagnostics, where he held simultaneous roles in private practice and as director of medical and scientific affairs, and then as the North American medical director for the molecular diagnostics, POC, diabetes, clinical chemistry, and immunology businesses.


Howard Jacob

Howard Jacob has joined AbbVie as vice president of the genomic research center, leaving the HudsonAlpha Institute of Biotechnology. He had served as vice president of medical genomics and chief medical officer there since 2015. Jacob also cofounded Envision Genomics, a spinout of HudsonAlpha that aimed to make whole-genome sequencing standard of care for rare disease diagnostics. Prior to joining HudsonAlpha, Jacob served for nearly 20 years at the Medical College of Wisconsin, including as founding director of the Human and Molecular Genetics Center and as a professor of physiology. Previous to that, he was on the faculty at Massachusetts General Hospital and Harvard Medical School.


Dawn Berry

Dawn Berry has become president of Luna DNA, a genomic and medical research database powered by the blockchain and owned by its community. Previously, she was vice president of applied genomics at Illumina, which she joined in 2005 as a market development specialist. Prior to that, she was with Genaissance Pharmaceuticals, promoting clinical genetics testing services for pharmaceutical trials. Berry holds a BS in biology from the University of Vermont and an MBA from the University of Connecticut School of Business.


For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.